Latest therapeutics News

MicroRNA is the Nobel-winning master regulator of the genome – researchers are learning to treat disease by harnessing how it controls genes
New Healthcare Agreement Translates Into Global Good
Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities
Percheron Therapeutics updates on Avicursen primate toxicology study
Nanoscope Therapeutics Licenses Optogenetic Technology
Multiple surgeries could contribute to cognitive decline in older people
INBRAIN Neuroelectronics Announces World’s First Human Graphene-Based Brain Computer Interface Procedure
Argenica reports positive results in IND-enabling trials
Chimeric announces new collaboration with Achieve Clinics
Center for NextGen Therapeutics helps match researchers to molecules
Accelerating Pioneering Inflammatory Diseases Research
Antiviral-resistant SARS-CoV-2 variants can emerge in immunocompromised people
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
Remembering Biotech Trailblazer Leon Serry AM
Study reveals how COVID-19 infection can cause or worsen diabetes
Top Perth Leukaemia Researcher Wins Prestigious Award
Cumming Global Centre for Pandemic Therapeutics and University of Bonn announce AUD$54 million partnership
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
PolyU and University of Waterloo partner to establish the Research Centre for Nanoscience and Nanotechnology for advanced applications
World-first Florey research aims to rapidly and accurately screen drugs to treat motor neurone disease
MRM Health Appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors
Construction starts on RNA research and manufacturing facility for NSW
Investing In Life Saving Technology
Strengthening Australia-Hong Kong health and investment ties
Percheron Therapeutics announces positive preclinical data for avicursen
New CRE for Nucleic Acid Sensing boosts RNA therapeutics
UQ Recognised In Life Sciences Queensland Awards
Chimeric says first patient dosed in trial of CDH17-directed CAR-T cell therapy
Emerging UQ Researchers Secure ARC Boost
De-mystifying Targeted Removal Of Red Blood Cells
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna’s COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1
Amplia says five patients recording sustained reduction in tumour size in trial
The Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program – Grant opportunities now open
Chimeric says Phase 1/2 CHM CDH17 CAR-T GMP manufacturing complete
Australia’s International Development Policy
Dan L Duncan Comprehensive Cancer Center launches Phase 1 Clinical Trial Program
Scientists unpack new information on exciting yet “ambiguous” drug receptor
WHO Director-General declares mpox outbreak a public health emergency of international concern
FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face
Do plastics cause autism? Here’s what the latest study really says
MRFF Funding Advances Hudson Institute RNA Therapies
ANU Researchers Working To Unlock Full Potential Of RNA
ANU researchers unlocking the full potential of RNA
Improving the Design of mRNA-loaded Nanocarriers for Targeted Therapies Researchers enhance stability and bioavailability of mRNA nanocarriers using triphenylphosphonium in polymeric micelles,…
Chimeric Therapeutics says first patient enrolled in cell therapy trial
Antiretrovirals in Pregnancy Research Toolkit
Alterity Therapeutics reports positive interim data from Multiple System Atrophy trial